CRINETICS PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Sales AgreementSales Agreement • June 21st, 2024 • Crinetics Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Crinetics Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Leerink Partners LLC and Cantor Fitzgerald & Co. (collectively the “Agents”, and each individually an “Agent”), as follows:
